DarioHealth, Dexcom Partner To Integrate CGM Into Digital Health Platform

Global digital therapeutics company DarioHealth has announced a partnership with Dexcom to integrate its continuous glucose monitors (CGMs) into Dario's multi-chronic condition platform.

Dexcom CGMs use a small, wearable sensor to continuously measure and send glucose levels to a receiver or smart device, enabling people with diabetes to make real-time decisions about their health. This agreement enables the integration of data from Dexcom CGMs directly into Dario's metabolic solution, making it easy for people using the wearable device to benefit from Dario's highly personalized support.

Dario's integrated digital health solution provides highly personalized support for people living with chronic conditions by using clinical, engagement and behavioural data to adapt each user's experience over time. Data from glucose monitoring devices such as Dario's proprietary smart meter and now Dexcom CGMs enable highly personalized journeys that guide users to the most effective and engaging path to better health.

"Nearly two million people use a continuous glucose monitor today, and the ability to capture that data in Dario's platform expands our ability to deliver a dynamic, highly relevant experience to more people living with diabetes. It's an exciting development that will ultimately benefit every Dario member as the CGM data enriches our overall data ecosystem," Rick Anderson, President of Dario said in a news release.

The integration with Dexcom builds on the collaboration between Dario and Sanofi US which aims to establish an ecosystem of dedicated technology partners and industry-leading digital therapeutics solutions.

Join the HealthXL Masterclass on ‘Endpoints and Control Arms in Trials for DTx’ on 15th February. Click here to Request to Join. 

Click here to read the original news story.